Overview
Dofetilide is a prescription medication classified as a class III antiarrhythmic agent. It is primarily used to treat atrial fibrillation and atrial flutter by blocking potassium channels in cardiac cells, thereby prolonging the action potential duration and refractory period. The drug was developed to provide a more targeted approach to managing irregular heart rhythms with fewer side effects compared to earlier antiarrhythmic drugs. As a selective potassium channel blocker, dofetilide has become an important tool in cardiology, particularly for patients who have not responded to other treatments. Its use is strictly monitored due to the potential for serious side effects, including life-threatening arrhythmias.
Physical and Chemical Properties
Dofetilide is a synthetic compound appearing as a white to off-white crystalline powder. Its molecular structure includes a sulfonamide group, which contributes to its pharmacological activity. The drug is slightly soluble in water but dissolves well in methanol, making it suitable for pharmaceutical formulations. The compound is stable under recommended storage conditions but may degrade when exposed to excessive heat, light, or moisture. Its melting point falls within the range of 180-182°C, typical for many pharmaceutical compounds. These properties are critical for manufacturing and quality control processes in drug production.
Main Applications
The primary medical application of dofetilide is in the treatment of atrial fibrillation and atrial flutter, two common cardiac arrhythmias. It is particularly useful for converting these arrhythmias to normal sinus rhythm and for maintaining normal heart rhythm after conversion. The drug is often prescribed when other therapies have failed or are contraindicated. In clinical practice, dofetilide is administered under strict medical supervision, typically beginning with hospitalization for monitoring. This precaution is necessary because the drug can paradoxically cause dangerous heart rhythms in some patients. Its use has been shown to be effective in selected patient populations when properly monitored.
Safety and Storage
Dofetilide carries significant safety considerations due to its potential to cause torsades de pointes, a life-threatening ventricular arrhythmia. Patients must be carefully selected based on kidney function, electrolyte levels, and other medications. Continuous cardiac monitoring is required during initiation of therapy. Proper storage of dofetilide involves protection from light and moisture at controlled room temperature. The drug should be kept in its original packaging until use. Pharmaceutical manufacturers and distributors must comply with Good Manufacturing Practices (GMP) to ensure product stability and quality throughout the supply chain.
B2B Procurement Guide
When procuring dofetilide in bulk quantities, pharmaceutical companies should verify suppliers' certifications and quality control processes. Key considerations include the supplier's compliance with current Good Manufacturing Practices (cGMP), batch testing documentation, and supply chain reliability. Purchasers should request certificates of analysis for each batch and confirm the product's purity and stability data. Given the drug's narrow therapeutic index, even minor variations in quality can have significant clinical implications. Long-term supply agreements with quality-focused manufacturers are recommended to ensure consistent product availability.
Related Manufacturers
- 主营：硫代癸烷、化学试剂、总镍试剂、多非利特、棕榈酸甲酯、正辛酸甲酯、仲丁基氯化镁、正庚基溴化镁、仲丁基溴化镁、棕榈酸异丙酯
- 主营：莪术二酮、人参皂苷rc、自制对照品、去甲基多非利特、淫羊藿次苷